All Episodes

April 10, 2025 7 mins

What Is Semaglutide, And How Does It Aid In Weight Loss?

Struggling with weight loss despite your best efforts? You're not alone, and it might not be your willpower that's the problem. Licensed nutritionist Catina Wilson breaks down how Semaglutide—a groundbreaking GLP-1 receptor agonist medication—is changing lives by targeting the biological factors that make weight loss so challenging.

The magic of Semaglutide lies in its three-fold approach: it signals fullness to your brain, eliminating those constant food cravings (what Catina calls "food noise"); it slows digestion so you stay satisfied longer after meals; and it regulates blood sugar levels. Originally developed for Type 2 diabetes, doctors noticed patients were losing significant weight—leading to its approval for weight management. The results speak for themselves, with many patients losing 5-7 pounds weekly and over 20 pounds monthly without the constant hunger or jitters associated with other weight loss medications.

Ready to silence those pizza cravings and transform your relationship with food? Visit online or call for your free weight loss consultation. Your future self will thank you for taking this first step today!

To learn more about Atlanta Wellness Clinic visit:
https://www.ATLWellnessClinic.com
Atlanta Wellness Clinic
1827 Powers Ferry Rd. SE, Bldg 1 STE 250
Atlanta, Georgia 30339
770-726-8978

Mark as Played
Transcript

Episode Transcript

Available transcripts are automatically generated. Complete accuracy is not guaranteed.
Speaker 1 (00:04):
Welcome to the Atlanta Wellness Clinic podcast
Hosted by licensed nutritionistand clinic owner, katina Wilson.
We're here to kickstart yourweight loss journey Because,
let's be honest, the only thingwe want gaining weight is our
wallets.
From medical weight loss andnutrition coaching to body
contouring, we help MetroAtlanta women get real results.

(00:24):
Let's dive in.

Speaker 2 (00:33):
Curious about semaglutide and its role in
weight loss.
Katina Wilson explains thisgroundbreaking medication is
change of the game for thosestruggling with obesity,
offering a scientifically backedmethod to support weight loss
and improve health.
Welcome back, Millie M Colson,producer, back in the studio
with Katina Wilson.
Katina, how are you?
I'm great.
How are you today Doing well,it's good to see you again.

(00:56):
Tell us what is semaglutide andhow does it aid in weight loss.

Speaker 3 (01:00):
All right, so semaglutide is a medication and
it belongs to a class of drugscalled GLP-1 receptor agonist.
Glp-1 stands for glucogen-likepeptide and it's a naturally
occurring hormone that's alreadyin our bodies, right?
It plays a significant role inregulating both blood sugar as

(01:22):
well as appetite.
So here's how the drug mimicsGLP-1s, and again, these GLP-1s
are actually in our bodies.
So first thing it does is itincreases satiety.
So it works with the brain andit signals to your brain that,
hey, I've eaten enough, you'refull.
So it automatically reduces theappetite and it reduces

(01:42):
cravings.
So you'll hear a lot of peopletalk about it reduces that food
noise, right.
So all of a sudden, that candybar that you typically crave or
me, being an emotional eater,sometimes I like to crave pizza
it gets rid of that food noise,right?
So that's kind of the first wayit works.
The next way it works is itslows down the digestion process

(02:03):
.
So now you're feeling full andnow the food is taking a little
bit longer to actually emptyfrom your body.
So not only is it working withthe brain, but it's slowing down
that gastric process as well.
And the third thing that it doesis it regulates blood sugar and
so many of these GLP-1medications.

(02:24):
They were initially prescribedfor people who had type two
diabetes, and so they werereally successful.
What they saw was that peoplewho were type 2 diabetic were
also starting to lose atremendous amount of weight, and
so the more they studied thismedicine, the two main factors
is it turns off that food noise,but then you stay full longer
because it takes longer for thedigestion process to happen.

(02:44):
So it's a really great medicinefor helping people achieve
their weight loss goals.

Speaker 2 (02:48):
So tell me, if someone is not type 2 diabetic
and they take this GLP-1, whatare the potential side effects
of using it simply for weightloss?

Speaker 3 (02:58):
Yeah, similar to those who are even type 2
diabetic.
So, first off, they take themedicine every single week.
So once a week, you know, yougive yourself a small injection,
but some of the side effectsthat we hear about could cause
nausea and vomiting.
It could also cause diarrheaand constipation.
What we're finding is the nauseaand vomiting happens for a
couple of reasons One, peoplearen't drinking enough water and

(03:20):
then two, with the medication,because it is slowing down that
digestive process, people areactually still trying to eat the
same way that they were eatingbefore, so their stomachs are
becoming kind of overly full,right, and so the body is just
saying look, a little too much,right?
Also because of that theslowing down of the digestive

(03:40):
process, some people experiencethe constipation and so
generally water helps with that.
Most of the time, what we seewith our patients and most of
our patients, I will tell you,because our doctors do try to
dose in a way where people arenot getting sick and, again, as
long as you're following like ameal plan, you know, and eating
kind of small meals and nottrying to overindulge, people

(04:02):
don't really get sick.
For the most part, if peopleare experiencing side effects,
it's very temporary.
It doesn't last very long, andthere's some over-the-counter
medications that can help withthat Worse.
Yet our doctors also canprescribe some anti-nausea
medications as well.

Speaker 2 (04:16):
Sounds good.
So is semaglutide suitable foreveryone, or is there some
specific criteria foreligibility?

Speaker 3 (04:24):
Yeah.
So I wouldn't say it's suitablefor everyone, right?
So if you're somebody who'strying to get ready for a big
event and you're just trying toget the last five pounds off,
it's probably not for you.
I mean, this is a very strongdrug.
So, like our doctors, they'vegotten some minimum standards
right.
Most people need to lose atleast a minimum of 10 pounds,
but then they also have a BMIbody mass index over 25, right?

(04:45):
So people who are over 25, nowyou're considered overweight,
you're considered obese when youstart to get into some of those
upper tiers numbers.
So those are some of the mostbasic.
We do have some where peoplewho've got like certain kinds of
chronic conditions, likepancreatitis and things like
that, it won't automaticallydisqualify you, but it certainly
will require a conversationwith a doctor.

(05:06):
But I'd say, like, the mostbasic things is like you know,
you're looking to lose 10 poundsand your BMI is a minimum of 25
.

Speaker 2 (05:14):
Good to know.
Also, how long does ittypically take for individuals
to see results when they get onthis medication?

Speaker 3 (05:21):
So it is going to vary by individual, but what I
can tell you is what we'reseeing with a lot of our
patients.
We're seeing people lose fiveto seven pounds in a week, Right
, and over 20 pounds in a month.
So again, it works really,really fast Now because we're
not running around chasing aftereverybody, making sure that
they're eating healthy andthey're not eating too much junk
food and that sort of a thing.
It does vary.
Men tend to lose weight alittle faster than women, but

(05:45):
that's almost obvious.
But generally speaking, what wesee is people are losing kind of
like five to seven pounds aweek.

Speaker 2 (05:52):
we see is, people are losing kind of like five to
seven pounds a week.
And how does this particularbecause I know in our last
episode you listed differentGLP-1s how does semaglutide
compare to other weight?

Speaker 3 (06:02):
loss medications on the market.
Yeah, so there are a couple ofgenerations of GLP-1s.
So semaglutide is the firstgeneration, gizepatide is the
second generation, and then theFDA is actually assessing a
third generation of the GLP-1s.
Right, those are not marketjust yet, but I'm sure within
the next 12 months we'll startto hear about the lightest and
greatest GLP-1 is.
How does it differ?

(06:22):
Some of the more popular, evenmedical, weight loss
prescriptions?
What people will say is I'mstill hungry or it's giving me
the jitters.
These GLP-1s don't do that.
They really kind of go afterthe things that make weight loss
hard, right.
So it goes after the cravingsand the constant thinking about
food, right.

(06:43):
And then it also goes afterthat feeling of hunger, right.
So between getting rid of andcanceling out the food noise and
slowing down the digestionprocess, it's kind of like the
double whammy where it's reallygoing after the things where
people struggle with weight loss.

Speaker 2 (06:59):
Well, thank you so much for joining us today,
katina.
We look forward to hearing morein the next episode.
Have a great day, thank you.
Have a great rest of your day.

Speaker 1 (07:13):
That's a wrap on this episode of the atlanta wellness
clinic podcast.
If you're ready to kickstartyour weight loss journey, and
not just your bathroom scale andfrustration, visit atl wellness
cliniccom or call us at770-726-8978 for a free
10-minute weight lossconsultation, because the best

(07:34):
time to start was yesterday.
The second best time right now.
See you next time.
Advertise With Us

Popular Podcasts

Stuff You Should Know
Dateline NBC

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

The Breakfast Club

The Breakfast Club

The World's Most Dangerous Morning Show, The Breakfast Club, With DJ Envy, Jess Hilarious, And Charlamagne Tha God!

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.